Quantcast

Latest Bioavailability Stories

2014-01-23 12:29:16

SAN DIEGO, Jan. 23, 2014 /PRNewswire/ -- Formex, LLC ("Formex"), a leader in pharmaceutical formulation and clinical trial manufacturing, announced today its sponsorship of the 3rd Drug Formulation & Bioavailability Conference to be held in Boston, MA from January 27-29, 2014. Formex CSO Blair West, Ph.D. will be joined by distinguished speakers from Merck & Co, F Hoffman-La Roche, Novartis and Boehringer-Ingelheim for a discussion entitled "Accelerating Time to Market...

2013-12-19 23:24:22

Aluronix Technologies Inc. has developed a new patented technology that enhances the health benefit of Hyaluronic Acid. Their soon to be released line of products will (1) allow the body to more efficiently absorb and metabolize Hyaluronan compounds, and (2) deliver them to where they are needed most. Montreal, QC (PRWEB) December 19, 2013 Aluronix Technologies Inc. has announced a new, patented method for significantly enhancing the effectiveness of Hyaluronic Acid health products. Using...

2013-11-19 23:30:15

Avail is conducting a randomized, multi-center study of the pharmacodynamics, pharmacokinetics, and tolerability of a new liquid form drug in adult patients with chronic idiopathic constipation. DeLand, FL (PRWEB) November 19, 2013 *To see if you qualify for this Constipation Clinical Trial in Florida, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance is required, and you may...

2013-11-19 23:26:07

ECOBOND® LBP successfully develops a lead poisoning prevention product to seal and treat lead paint hazards and reduce relative lead bioavailability to reduce the potential for childhood lead poisoning. Denver, CO (PRWEB) November 19, 2013 According to the US EPA, the leading cause of childhood lead poisoning is lead paint exposure. Although there is national focus on reducing lead paint hazards, especially for children; with up to 80% of all structures in the United States...

2013-10-25 23:01:40

Integral BioSystems LLC now has exclusive rights to the name it coined for its ophthalmic platform pharmaceutical formulation development product, OcuSurf™, offering an innovative approach for those interested in developing ophthalmic medications with enhanced persistence and bioavailability for front-of-the-eye application. (PRWEB) October 25, 2013 Integral BioSystems LLC, led by 20+ year veteran of drug formulation development Shikha P. Barman, Ph.D., now offers clients formulation...

2013-10-21 23:24:02

Xtalks presents an exciting live webinar on Wednesday October 30, 2013 at 11:00 am EDT, with keynote speaker Dr. David Vodak, Vice President of Chemistry at Bend Research Inc., on the advancements in bioavailability in the life sciences. Toronto, Canada (PRWEB) October 21, 2013 Compounds that require bioavailability enhancement to achieve target absorption are increasingly common in current pipelines. These compounds must be paired with various technologies to enable progression. This...

2013-10-10 23:03:27

Reportbuyer.com just published a new market research report: Analysis of the North American Oral Solid Drug Dosage Excipients Market. London (PRWEB) October 10, 2013 Blockbuster Drug Patent Expiration Expected to Boost Market Growth Excipients are used to support the delivery of the APIs (active pharmaceutical ingredients) through oral dosage, parenteral, and transdermal medications. For oral dosages, the key delivery forms are tablets and capsules. This research service covers the North...

2013-08-08 23:20:33

Patent Covers Composition of LunaRich Material and Technology Promoting Bioavailability Chesterfield, MO (PRWEB) August 08, 2013 Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that LunaRich® has earned a new patent from the US Patent and Trademark Office. The composition of matter patent protects the LunaRich technology as it relates to its superior ability to deliver bioactive lunasin to the body. Lunasin is...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related